These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14990720)

  • 1. Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection.
    Rutigliano JA; Johnson TR; Hollinger TN; Fischer JE; Aung S; Graham BS
    J Virol; 2004 Mar; 78(6):3014-23. PubMed ID: 14990720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.
    Johnson TR; Hong S; Van Kaer L; Koezuka Y; Graham BS
    J Virol; 2002 May; 76(9):4294-303. PubMed ID: 11932395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
    Aung S; Tang YW; Graham BS
    J Virol; 1999 Nov; 73(11):8944-9. PubMed ID: 10515999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice.
    Kulkarni AB; Connors M; Firestone CY; Morse HC; Murphy BR
    J Virol; 1993 Feb; 67(2):1044-9. PubMed ID: 8419638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
    Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
    Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonistic 4-1BB antibody fails to reduce disease burden during acute respiratory syncytial virus (RSV) infection.
    Norris MJ; Duan W; Cen Y; Moraes TJ
    Antiviral Res; 2016 Jan; 125():46-50. PubMed ID: 26597692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection.
    DiNapoli JM; Murphy BR; Collins PL; Bukreyev A
    Virol J; 2008 Sep; 5():105. PubMed ID: 18816384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.
    Chang J; Srikiatkhachorn A; Braciale TJ
    J Immunol; 2001 Oct; 167(8):4254-60. PubMed ID: 11591747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease.
    Aung S; Rutigliano JA; Graham BS
    J Virol; 2001 Oct; 75(20):9918-24. PubMed ID: 11559824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.
    Haynes LM; Tonkin J; Anderson LJ; Tripp RA
    J Virol; 2002 Jul; 76(14):6873-81. PubMed ID: 12072488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for admission and the role of respiratory syncytial virus-specific cytotoxic T-lymphocyte responses in children with acute bronchiolitis.
    Jeena PM; Ayannusi OE; Annamalai K; Naidoo P; Coovadia HM; Guldner P
    S Afr Med J; 2003 Apr; 93(4):291-4. PubMed ID: 12806723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo.
    Beyer M; Wang H; Peters N; Doths S; Koerner-Rettberg C; Openshaw PJ; Schwarze J
    Respir Res; 2005 Jul; 6(1):70. PubMed ID: 16011799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.
    Fischer JE; Johnson JE; Kuli-Zade RK; Johnson TR; Aung S; Parker RA; Graham BS
    J Virol; 1997 Nov; 71(11):8672-7. PubMed ID: 9343225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children.
    Mbawuike IN; Wells J; Byrd R; Cron SG; Glezen WP; Piedra PA
    J Infect Dis; 2001 Mar; 183(5):687-96. PubMed ID: 11181144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection.
    Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM
    J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
    Srikiatkhachorn A; Braciale TJ
    J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.
    Tang YW; Graham BS
    J Clin Invest; 1994 Nov; 94(5):1953-8. PubMed ID: 7962541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
    Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
    J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus.
    Vallbracht S; Jessen B; Mrusek S; Enders A; Collins PL; Ehl S; Krempl CD
    J Immunol; 2007 Dec; 179(12):8264-73. PubMed ID: 18056370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.